Current Cardiovascular Risk Reports

, Volume 7, Issue 2, pp 154–162 | Cite as

Saturated Fat and Cardiovascular Disease: A Review of Current Evidence

  • Majella O’Keeffe
  • Marie-Pierre St-OngeEmail author
Obesity and Diet (G Rao, Section Editor)


Cardiovascular disease (CVD) is one of the leading causes of death throughout the world. Saturated fatty acids (SFA) have long been implicated in the development of CVD. The evidence to support this hypothesis came from studies which examined the effects of SFA intake on total cholesterol (TC). However, relying on TC as the sole primary outcome may not be sufficient and understanding the effect of SFA on the concentrations of other lipid fractions is necessary. SFA are known to increase low-density lipoprotein cholesterol (LDL-C) and consequently dietary guidelines recommend reducing SFA intakes in order to decrease LDL-C and CVD risk. However, recent evidence suggests that not all SFAs possess the same atherogenic properties but this development has not yet been reflected in dietary recommendations. This review summarizes recent evidence on the relationship between SFA intake and CVD risk. It also explores current dietary guidelines specific to SFA intake and outlines why future guidelines may need to be food- rather than nutrient-specific. Overall, the evidence presented in this review suggests that not all SFA are created equal and the food sources of SFA, as well as individual characteristics of the SFA, such as chain length, should be considered in dietary recommendations.


Cardiovascular disease Saturated fat Dairy Meat Dietary guidelines 



American Heart Association


Beef Optimal in Lean Diet


Coronary heart disease


C-reactive protein


Cardiovascular disease


Dietary Approaches to Stop Hypertension


European Food Safety Authority


Food frequency questionnaire


Healthy American Diet


High-density lipoprotein cholesterol








Interferon gamma


Institute of Medicine


Low-density lipoprotein cholesterol


Mono-unsaturated fatty acid


Saturated fatty acids


Total cholesterol




Tumor necrosis factor-alpha


United States Department of Agriculture


United States Department of Health and Human Services



No potential conflicts of interest relevant to this article were reported.


  1. 1.
    Deaton C et al. The global burden of cardiovascular disease. Eur J Cardiovasc Nurs. 2011;10(2):S5–13.PubMedCrossRefGoogle Scholar
  2. 2.
    Celermajer DS et al. Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. J Am Coll Cardiol. 2012;60(14):1207–16.PubMedCrossRefGoogle Scholar
  3. 3.
    Ergin A et al. Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States. Am J Med. 2004;117(4):219–27.PubMedCrossRefGoogle Scholar
  4. 4.
    Roger VL et al. Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–e220.PubMedCrossRefGoogle Scholar
  5. 5.
    Xu J., et al. Deaths: final data for 2007, 2010, National Center for Health Statistics: Hyattsville, MD. p. 1-135.Google Scholar
  6. 6.
    Thom T et al. Heart disease and stroke statistics–2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113(6):e85–151.PubMedCrossRefGoogle Scholar
  7. 7.
    Mensah GA et al. State of disparities in cardiovascular health in the United States. Circulation. 2005;111(10):1233–41.PubMedCrossRefGoogle Scholar
  8. 8.
    CDC, Racial/ethnic and socioeconomic disparities in multiple risk factors for heart disease and stroke–United States, 2003. in Morbidity and Mortality Weekly Report 2003.113-7.Google Scholar
  9. 9.
    Long Y et al. Analysis of the prevalence of cardiovascular disease and associated risk factors for European-American and African-American Populations in the State of Pennsylvania 2005-2009. Am J Cardiol. 2012. doi: 10.1016/j.amjcard.2012.08.045.
  10. 10.
    Hertz RP et al. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165(18):2098–104.PubMedCrossRefGoogle Scholar
  11. 11.
    Keys A et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol. 1986;124(6):903–15.PubMedGoogle Scholar
  12. 12.
    Keys A, Blackburn H, Menotti A. Coronary heart disease in seven countries. Circulation. 1970;41(1):1–211.CrossRefGoogle Scholar
  13. 13.
    Keys A. Coronary heart disease in seven countries. Circulation. 1970;41(S1):1–211.Google Scholar
  14. 14.
    Keys A et al. The seven countries study: 2,289 deaths in 15 years. Prev Med. 1984;13(2):141–54.PubMedCrossRefGoogle Scholar
  15. 15.
    Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA. 1987;257(16):2176–80.PubMedCrossRefGoogle Scholar
  16. 16.
    Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA 1982;248(12):1465-77.Google Scholar
  17. 17.
    Kushi LH et al. Diet and 20-year mortality from coronary heart disease. The Ireland-Boston Diet-Heart Study. N Engl J Med. 1985;312(13):811–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Astrup A et al. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am J Clin Nutr. 2011;93(4):684–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Volk MG. An examination of the evidence supporting the association of dietary cholesterol and saturated fats with serum cholesterol and development of coronary heart disease. Altern Med Rev. 2007;12(3):228–45.PubMedGoogle Scholar
  20. 20.
    Ravnskov U. A hypothesis out-of-date. the diet-heart idea. J Clin Epidemiol. 2002;55(11):1057–63.PubMedCrossRefGoogle Scholar
  21. 21.
    Hoenselaar R. Saturated fat and cardiovascular disease: the discrepancy between the scientific literature and dietary advice. Nutrition. 2012;28(2):118–23.PubMedCrossRefGoogle Scholar
  22. 22.
    USDA/UDHHS, Report of the Dietary Guidelines Advisory Committee on the dietary guidelines for Americans, 2010, U.S.D.o. Agriculture and U.S.D.o.H.a.H. Services, Editors. 2010.Google Scholar
  23. 23.
    American Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie-Rosett J. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006;114(1):82-96.Google Scholar
  24. 24.
    Medicine, I.O., Dietary fats: total fat and fatty acids. In: Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids (macronutrients), 2005.Google Scholar
  25. 25.
    EFSA, Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. ESFA J. 2010;8(3):1461.Google Scholar
  26. 26.
    Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7(3):e1000252.PubMedCrossRefGoogle Scholar
  27. 27.
    Beulens JW et al. High dietary glycemic load and glycemic index increase risk of cardiovascular disease among middle-aged women: a population-based follow-up study. J Am Coll Cardiol. 2007;50(1):14–21.PubMedCrossRefGoogle Scholar
  28. 28.
    Levitan EB et al. Dietary glycemic index, dietary glycemic load, and cardiovascular disease in middle-aged and older Swedish men. Am J Clin Nutr. 2007;85(6):1521–6.PubMedGoogle Scholar
  29. 29.
    Sacks FM, Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med. 2002;113(Suppl 9B):13S–24S.PubMedCrossRefGoogle Scholar
  30. 30.
    van Dam RM et al. Dietary glycemic index in relation to metabolic risk factors and incidence of coronary heart disease: the Zutphen Elderly Study. Eur J Clin Nutr. 2000;54(9):726–31.PubMedCrossRefGoogle Scholar
  31. 31.
    Bolland MJ et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691.PubMedCrossRefGoogle Scholar
  32. 32.
    Soedamah-Muthu SS et al. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am J Clin Nutr. 2011;93(1):158–71.PubMedCrossRefGoogle Scholar
  33. 33.
    van Aerde, M.A., et al., Dairy intake in relation to cardiovascular disease mortality and all-cause mortality: the Hoorn Study. Eur J Nutr. 2012;Google Scholar
  34. 34.
    Bernstein AM et al. Major dietary protein sources and risk of coronary heart disease in women. Circulation. 2010;122(9):876–83.PubMedCrossRefGoogle Scholar
  35. 35.
    Goldbohm RA et al. Dairy consumption and 10-y total and cardiovascular mortality: a prospective cohort study in the Netherlands. Am J Clin Nutr. 2011;93(3):615–27.PubMedCrossRefGoogle Scholar
  36. 36.
    Sonestedt E et al. Dairy products and its association with incidence of cardiovascular disease: the Malmo diet and cancer cohort. Eur J Epidemiol. 2011;26(8):609–18.PubMedCrossRefGoogle Scholar
  37. 37.
    Elwood PC et al. The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids. 2010;45(10):925–39.PubMedCrossRefGoogle Scholar
  38. 38.
    German JB et al. A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. Eur J Nutr. 2009;48(4):191–203.PubMedCrossRefGoogle Scholar
  39. 39.
    Mozaffarian D, Aro A, Willett WC. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr. 2009;63 Suppl 2:S5–21.PubMedCrossRefGoogle Scholar
  40. 40.
    Malpuech-Brugere C et al. Differential impact of milk fatty acid profiles on cardiovascular risk biomarkers in healthy men and women. Eur J Clin Nutr. 2010;64(7):752–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Intorre F et al. Differential effect of cheese fatty acid composition on blood lipid profile and redox status in normolipidemic volunteers: a pilot study. Int J Food Sci Nutr. 2011;62(6):660–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Ivey KL et al. Association between yogurt, milk, and cheese consumption and common carotid artery intima-media thickness and cardiovascular disease risk factors in elderly women. Am J Clin Nutr. 2011;94(1):234–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Hodis HN et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128(4):262–9.PubMedGoogle Scholar
  44. 44.
    Hjerpsted J, Leedo E, Tholstrup T. Cheese intake in large amounts lowers LDL-cholesterol concentrations compared with butter intake of equal fat content. Am J Clin Nutr. 2011;94(6):1479–84.PubMedCrossRefGoogle Scholar
  45. 45.
    Everett DW, Auty MAE. Cheese structure and current methods of analysis. Int Dairy J. 2008;18:759–73.CrossRefGoogle Scholar
  46. 46. Sources of Saturated Fat, Stearic Acid, & Cholesterol Raising Fat among the US Population, 2005–06. 2010 [cited 2012 November 28].
  47. 47.
    Sinha R et al. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med. 2009;169(6):562–71.PubMedCrossRefGoogle Scholar
  48. 48.
  49. 49.
    Linseisen J et al. Meat consumption in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts: results from 24-hour dietary recalls. Public Health Nutr. 2002;5(6B):1243–58.PubMedCrossRefGoogle Scholar
  50. 50.
    Maki KC et al. A meta-analysis of randomized controlled trials that compare the lipid effects of beef versus poultry and/or fish consumption. J Clin Lipidol. 2012;6(4):352–61.PubMedCrossRefGoogle Scholar
  51. 51.
    Mensink RP. Effects of the individual saturated fatty acids on serum lipids and lipoprotein concentrations. Am J Clin Nutr. 1993;57(5 Suppl):711S–4S.PubMedGoogle Scholar
  52. 52.
    Kris-Etherton PM, Yu S. Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr. 1997;65(5 Suppl):1628S–44S.PubMedGoogle Scholar
  53. 53.
    Hunter JE, Zhang J, Kris-Etherton PM. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr. 2010;91(1):46–63.PubMedCrossRefGoogle Scholar
  54. 54.
    Bonanome A, Grundy SM. Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels. N Engl J Med. 1988;318(19):1244–8.PubMedCrossRefGoogle Scholar
  55. 55.
    Kaluza J, Wolk A, Larsson SC. Red meat consumption and risk of stroke: a meta-analysis of prospective studies. Stroke. 2012;43(10):2556–60.PubMedCrossRefGoogle Scholar
  56. 56.
    Kimura Y et al. Meat, fish and fat intake in relation to subsite-specific risk of colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci. 2007;98(4):590–7.PubMedCrossRefGoogle Scholar
  57. 57.
    Fraser GE. Associations between diet and cancer, ischemic heart disease, and all-cause mortality in non-Hispanic white California Seventh-day Adventists. Am J Clin Nutr. 1999;70(3 Suppl):532S–8S.PubMedGoogle Scholar
  58. 58.
    Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation. 2010;121(21):2271–83.PubMedCrossRefGoogle Scholar
  59. 59.
    Larsson SC, Virtamo J, Wolk A. Red meat consumption and risk of stroke in Swedish men. Am J Clin Nutr. 2011;94(2):417–21.PubMedCrossRefGoogle Scholar
  60. 60.
    Wang L et al. Meat intake and the risk of hypertension in middle-aged and older women. J Hypertens. 2008;26(2):215–22.PubMedCrossRefGoogle Scholar
  61. 61.
    Ashaye A, Gaziano J, Djousse L. Red meat consumption and risk of heart failure in male physicians. Nutr Metab Cardiovasc Dis. 2011;21(12):941–6.PubMedCrossRefGoogle Scholar
  62. 62.
    Roussell MA et al. Beef in an Optimal Lean Diet study: effects on lipids, lipoproteins, and apolipoproteins. Am J Clin Nutr. 2012;95(1):9–16.PubMedCrossRefGoogle Scholar
  63. 63.
    St-Onge MP et al. Baseline serum C-reactive protein is associated with lipid responses to low-fat and high-polyunsaturated fat diets. J Nutr. 2009;139(4):680–3.PubMedCrossRefGoogle Scholar
  64. 64.
    Hilpert KF, Kris-Etherton PM, West SG. Lipid response to a low-fat diet with or without soy is modified by C-reactive protein status in moderately hypercholesterolemic adults. J Nutr. 2005;135(5):1075–9.PubMedGoogle Scholar
  65. 65.
    Desroches S et al. Baseline plasma C-reactive protein concentrations influence lipid and lipoprotein responses to low-fat and high monounsaturated fatty acid diets in healthy men. J Nutr. 2006;136(4):1005–11.PubMedGoogle Scholar
  66. 66.
    Arsenault BJ et al. HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Atherosclerosis. 2009;206(1):276–81.PubMedCrossRefGoogle Scholar
  67. 67.
    El Harchaoui K et al. High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med. 2009;150(2):84–93.PubMedGoogle Scholar
  68. 68.
    Mateo-Gallego, R., et al., Effect of lean red meat from lamb v. lean white meat from chicken on the serum lipid profile: a randomised, cross-over study in women. Br J Nutr. 2012;107(10):1403-7.Google Scholar
  69. 69.
    Willett WC. The Mediterranean diet: science and practice. Public Health Nutr. 2006;9(1A):105–10.PubMedCrossRefGoogle Scholar
  70. 70.
    St-Onge MP et al. Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. Obes Res. 2003;11(3):395–402.PubMedCrossRefGoogle Scholar
  71. 71.
    Han JR et al. Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism. 2007;56(7):985–91.PubMedCrossRefGoogle Scholar
  72. 72.
    St-Onge MP, Bosarge A. Weight-loss diet that includes consumption of medium-chain triacylglycerol oil leads to a greater rate of weight and fat mass loss than does olive oil. Am J Clin Nutr. 2008;87(3):621–6.PubMedGoogle Scholar
  73. 73.
    Denke MA, Grundy SM. Comparison of effects of lauric acid and palmitic acid on plasma lipids and lipoproteins. Am J Clin Nutr. 1992;56(5):895–8.PubMedGoogle Scholar
  74. 74.
    Schwab US et al. Lauric and palmitic acid-enriched diets have minimal impact on serum lipid and lipoprotein concentrations and glucose metabolism in healthy young women. J Nutr. 1995;125(3):466–73.PubMedGoogle Scholar
  75. 75.
    Voon PT et al. Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. Am J Clin Nutr. 2011;94(6):1451–7.PubMedCrossRefGoogle Scholar
  76. 76.
    Mensink RP et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77(5):1146–55.PubMedGoogle Scholar
  77. 77.
    Oguntibeju OO, Esterhuyse AJ, Truter EJ. Red palm oil: nutritional, physiological and therapeutic roles in improving human wellbeing and quality of life. Br J Biomed Sci. 2009;66(4):216–22.PubMedGoogle Scholar
  78. 78.
    Edem DO. Palm oil: biochemical, physiological, nutritional, hematological, and toxicological aspects: a review. Plant Foods Hum Nutr. 2002;57(3–4):319–41.PubMedCrossRefGoogle Scholar
  79. 79.
    Chiu MC, De C, Coutinho M, Aparecida L, Goncalves G. Carotenoid concentration of red palm oil using membrane technology. Desalination. 2009;246:410–3.Google Scholar
  80. 80.
    Karupaiah T et al. The chain length of dietary saturated fatty acids affects human postprandial lipemia. J Am Coll Nutr. 2011;30(6):511–21.PubMedGoogle Scholar
  81. 81.
    Ooi TC et al. Postprandial remnant-like lipoproteins in hypertriglyceridemia. J Clin Endocrinol Metab. 2001;86(7):3134–42.PubMedCrossRefGoogle Scholar
  82. 82.
    Havel RJ. Remnant lipoproteins as therapeutic targets. Curr Opin Lipidol. 2000;11(6):615–20.PubMedCrossRefGoogle Scholar
  83. 83.
    Tholstrup T, Teng KT, Raff M. Dietary cocoa butter or refined olive oil does not alter postprandial hsCRP and IL-6 concentrations in healthy women. Lipids. 2011;46(4):365–70.PubMedCrossRefGoogle Scholar
  84. 84.
    Tholstrup T, Hjerpsted J, Raff M. Palm olein increases plasma cholesterol moderately compared with olive oil in healthy individuals. Am J Clin Nutr. 2011;94(6):1426–32.PubMedCrossRefGoogle Scholar
  85. 85.
    DebMandal M, Mandal S. Coconut (Cocos nucifera L.: Arecaceae): in health promotion and disease prevention. Asian Pac. J Trop Med. 2011;4(3):241–7.Google Scholar
  86. 86.
    Stamler J. Diet-heart: a problematic revisit. Am J Clin Nutr. 2010;91(3):497–9.PubMedCrossRefGoogle Scholar
  87. 87.
    Siri-Tarino PW et al. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010;91(3):535–46.PubMedCrossRefGoogle Scholar
  88. 88.
    USDA. 2011 [cited 2012 December 1].

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Kings College London, School of Medicine, Diabetes and Nutritional Science DivisionLondonUK
  2. 2.New York Obesity Nutrition Research Centre, St. Luke’s/Roosevelt HospitalNew YorkUSA
  3. 3.College of Physicians and Surgeons, Columbia UniversityNew YorkUSA
  4. 4.New York Nutrition Obesity Research CentreNew YorkUSA

Personalised recommendations